Condition
Glioma Glioblastoma Multiforme clinical trials and research
Research outlook What's coming for Glioblastoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Glioma Glioblastoma Multiforme clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Iran (1), Italy (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Glioma Glioblastoma Multiforme clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Midline glioma MRI AI model: preoperative molecular subtyping and prognosis | — | Changsha, Hunan | Recruiting | May 27, 2026 |
| PET-guided surgery for high-grade glioma | — | Torino, Turin and 1 other locations | Recruiting | May 5, 2026 |
| Testing TNG456 and Abemaciclib in Patients with Solid Tumors Lacking MTAP | Phase 1/2 | Scottsdale, Arizona and 14 other locations | Recruiting | Feb 5, 2025 |
| Injection of natural killer cells for treating gliomas | Phase 2 | Tehran | Recruiting | Nov 13, 2024 |
| Personalized delivery of tumor treating fields for glioblastoma patients | — | Philadelphia, Pennsylvania and 1 other locations | Recruiting | Oct 21, 2021 |
All recruiting trials (5)
-
Midline glioma MRI AI model: preoperative molecular subtyping and prognosis
This study tests an MRI-based AI model to predict key molecular subtypes and prognosis for patients with midline gliomas before surgery.
-
PET-guided surgery for high-grade glioma
This project will try using 18F-DOPA PET to guide surgeons to remove tumor beyond MRI-visible areas in adults with high-grade glioma to see if it delays progression and extends survival.
-
Testing TNG456 and Abemaciclib in Patients with Solid Tumors Lacking MTAP
This study is testing a new drug called TNG456, alone and with another drug called abemaciclib, to see if it helps people with advanced solid tumors that have lost a specific gene called MTAP.
-
Injection of natural killer cells for treating gliomas
This study is testing whether a new treatment using natural killer cells can help young patients with high-grade gliomas, like glioblastoma, fight their cancer better.
-
Personalized delivery of tumor treating fields for glioblastoma patients
This study is testing if a new way of mapping brain tumors can help glioblastoma patients using Optune treatment live longer and feel better compared to the standard method.
Related topics
Quick answers
How many Glioma Glioblastoma Multiforme clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Iran (1 trial), Italy (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.